- Home
- OTTR vs AXSM Comparison
OTTR vs AXSM Comparison
Compare OTTR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTTR
- AXSM
- Stock Information
- Founded
- OTTR 1907
- AXSM 2012
- Country
- OTTR United States
- AXSM United States
- Employees
- OTTR N/A
- AXSM N/A
- Industry
- OTTR Electric Utilities: Central
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- OTTR Utilities
- AXSM Health Care
- Exchange
- OTTR Nasdaq
- AXSM Nasdaq
- Market Cap
- OTTR 3.5B
- AXSM 4.0B
- IPO Year
- OTTR N/A
- AXSM 2015
- Fundamental
- Price
- OTTR $77.81
- AXSM $94.09
- Analyst Decision
- OTTR
- AXSM Strong Buy
- Analyst Count
- OTTR 0
- AXSM 14
- Target Price
- OTTR N/A
- AXSM $124.57
- AVG Volume (30 Days)
- OTTR 189.2K
- AXSM 412.8K
- Earning Date
- OTTR 08-05-2024
- AXSM 11-04-2024
- Dividend Yield
- OTTR 2.40%
- AXSM N/A
- EPS Growth
- OTTR 14.71
- AXSM N/A
- EPS
- OTTR 7.40
- AXSM N/A
- Revenue
- OTTR $1,361,773,000.00
- AXSM $291,489,000.00
- Revenue This Year
- OTTR $6.51
- AXSM $42.50
- Revenue Next Year
- OTTR $4.52
- AXSM $69.28
- P/E Ratio
- OTTR $10.55
- AXSM N/A
- Revenue Growth
- OTTR N/A
- AXSM 59.73
- 52 Week Low
- OTTR $68.96
- AXSM $55.02
- 52 Week High
- OTTR $100.84
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- OTTR 30.83
- AXSM 66.24
- Support Level
- OTTR $83.15
- AXSM $91.52
- Resistance Level
- OTTR $92.51
- AXSM $97.00
- Average True Range (ATR)
- OTTR 2.45
- AXSM 2.95
- MACD
- OTTR -1.03
- AXSM 0.49
- Stochastic Oscillator
- OTTR 3.80
- AXSM 72.93
About OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.